Advansix reported Q326 sales of $431 million, up 15% year-over-year, while adjusted diluted EPS was negative ($0.24) due to reduced output and higher input costs. The company also secured a $47 million Fields Grant for its ammonia platform.
Advansix reported Q326 sales of $431 million, up 15% year-over-year, while adjusted diluted EPS was negative ($0.24) due to reduced output and higher input costs. The company also secured a $47 million Fields Grant for its ammonia platform.